CVS Health Corp (CVS)

CVS (NYSE:Health Services) EQUITY
$104.75
neg -0.80
-0.76%
Today's Range: 103.63 - 105.77 | CVS Avg Daily Volume: 4,422,300
Last Update: 07/06/15 - 1:52 PM EDT
Volume: 2,018,264
YTD Performance: 9.59%
Open: $103.63
Previous Close: $105.55
52 Week Range: $74.69 - $106.88
Oustanding Shares: 1,128,330,774
Market Cap: 119,095,313,196
6-Month Chart
TheStreet Ratings Grade for CVS
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 14 12 13 13
Moderate Buy 3 3 3 3
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.25 1.28 1.26 1.26
Latest Dividend: 0.35
Latest Dividend Yield: 1.33%
Dividend Ex-Date: 04/22/15
Price Earnings Ratio: 25.87
Price Earnings Comparisons:
CVS Sector Avg. S&P 500
25.87 25.80 26.10
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
2.77% 38.43% 120.77%
GROWTH 12 Mo 3 Yr CAGR
Revenue 9.90 0.30 0.09
Net Income 1.10 0.33 0.10
EPS 5.90 0.54 0.15
Earnings for CVS:
EBITDA 10.73B
Revenue 139.37B
Average Earnings Estimates
Qtr (06/15) Qtr (09/15) FY (12/15) FY (12/16)
Average Estimate $1.20 $1.37 $5.16 $5.91
Number of Analysts 22 22 24 25
High Estimate $1.22 $1.44 $5.25 $6.19
Low Estimate $1.18 $1.31 $5.09 $5.60
Prior Year $1.13 $1.15 $4.22 $5.16
Growth Rate (Year over Year) 5.95% 19.01% 22.38% 14.52%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Update
Jun 23, 2015 | 6:52 AM EDT
Jefferies Consumer Conference (Day 1 of 2) - 06/23/15 - 06/24/15 Nantucket, MA
Bullish
Jun 18, 2015 | 7:26 AM EDT
CVS was initiated with an Outperform rating, Oppenheimer said. $119 price target. Focus on health can drive growth. 
It is a win-win for the companies and stocks.
Margins continue to be hurt by incentives and concessions.
Both chains' new CEOs are shaking things up, but TGT is winning.
Take advantage of irrational collateral damage to stocks.
We applaud the deal with CVS Health, which allows Target to focus on its more profitable categories.
But investors are likely to be wary ahead of the Fed meeting.
Will it get involved in health care sector's deal mania?
Deals coming fast and furious in the best group in town.

Columnist Conversations

LVS is trading well(+1.4%)again today. Last week the stock, along with the other casino names, surged on very...
Markets having much better day than futures would have indicated. Investors should be patient here, there are...
Euclid Tsakalotos, an Oxford educated economist is named to replace Yanis Varoufakis as the new Finance Minist...
Hi all, good morning. Back in the office again today. Greece? Great musical. Markets have been dancing to this...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.